47045-IRN-H-UNDP-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative xml:lang="en">United Nations Development Programme, Iran - Iran (Islamic Republic) (01-Apr-2015-31-Mar-2018)</narrative> Iran (Islamic Republic), HIV, United Nations Development Programme (UNDP Iran)This program has the following goals: Decreased AIDS mortality rate in identified HIV positive cases by 20%.. Decreased rate of HIV prevalence among newborns of HIV infected mothers who delivered in the past 12 months by 90%. Maintaining the HIV prevalence rate among men and women with the most high-risk sexual behaviors at less than 5%. Maintaining the HIV prevalence rate at less than 13% among IDUs. The objectives of this program are: Objective 1: By the end of 2019, at least 95% of the IDUs should use sterilized and non-shared devices for injection in their last injection. Objective 2: By the end of 2019, the percentage of VW who have used condom in their latest last sexual contact should reach 60%. Objective 3: By the end of 2019, 90% of the estimated pregnant women infected with HIV should be covered by standard treatments in line with prevention of mother-to-child transmission. Objective 4: By the end of 2019, more than 90% of the advanced HIV/AIDS infection cases who have started their treatment a year ago, will adhere to treatment The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division Olivier, CAVEY Fund Portfolio Manager +41 58 791 1700 olivier.cavey@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Iran (Islamic Republic) HIV 6360470.00 Global Fund Commitment to IRN-H-UNDPP01. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) -682460.00 Global Fund Commitment to IRN-H-UNDPP01. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 3495234.00 Global Fund Commitment to IRN-H-UNDPP01. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 2755678.00 Global Fund Commitment to IRN-H-UNDPP01. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 2713047.00 Global Fund disbursement to IRN-H-UNDPP01. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 1949800.00 Global Fund disbursement to IRN-H-UNDPP01. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 2108227.00 Global Fund disbursement to IRN-H-UNDPP01. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 1500244.00 Global Fund disbursement to IRN-H-UNDPP01. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 1464719.00 Global Fund disbursement to IRN-H-UNDPP01. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 1387007.00 Global Fund disbursement to IRN-H-UNDPP01. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 805878.00 Global Fund disbursement to IRN-H-UNDPP01. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) <narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative> An overview of a grant over it's lifetime. <narrative xml:lang="en">Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative xml:lang="en">Coverage / Output indicators targets and results for IRN-H-UNDPP01</narrative> <narrative xml:lang="en">KP Other-5: Percentage of students that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative> <narrative xml:lang="en">TCS Other-1:Percentage of PLWH receiving counseling and psycho-social support services</narrative> <narrative xml:lang="en">KP Other-3: Percentage of children with drug problems reached with HIV prevention programs - defined package of services</narrative> <narrative xml:lang="en">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative> <narrative xml:lang="en">KP Other-2: Percentage of ATS users that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> <narrative xml:lang="en">Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative> <narrative xml:lang="en">Percentage of people living with HIV and on ART, who have a suppressed viral load at 12 months (<1000 copies/ml)</narrative> <narrative xml:lang="en">Percentage of pregnant women who know their HIV status</narrative> <narrative xml:lang="en">KP Other-1: Percentage of ATS users reached with HIV prevention programs - defined package of services</narrative> <narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative> <narrative xml:lang="en">Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> <narrative xml:lang="en">KP Other 4: Percentage of children with drug problem that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Number of needles and syringes distributed per person who injects drugs per year by needle and syringe programs</narrative> <narrative xml:lang="en">Outcome indicators targets and results for IRN-H-UNDPP01</narrative> <narrative xml:lang="en">Percentage of adults and children with HIV, known to be on treatment 12 months after initiation of antiretroviral therapy</narrative> 47045-IRN-H-UNDP-2 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative xml:lang="en">Enhancement of National HIV Response with Focus on Target Beneficiary Groups in line with fourth National Strategic Plan 2015-2019 - Iran (Islamic Republic) (01-Apr-2018-31-Mar-2021)</narrative> Iran (Islamic Republic), HIV, United Nations Development Programme (UNDP Iran)This program has the following goals: By the end of 2019, maintain the HIV prevalence rate at less than 13% among PWIDs.. By the end of 2019 maintain the HIV prevalence rate among men and women with the most high-risk sexual behaviors at less than 5%. By the end of 2019 decrease AIDS mortality rate in identified HIV positive cases by 20% compared to the baseline of the 4th NSP. The objectives of this program are: By end of 2019, at least 90% of PWIDs used sterile injecting equipment the last time they injected. By the end of 2019, at least 60% of the PWIDs have done HIV testing through PIT approach. By the end of 2019, at least 50% of the VWs have done HIV testing through PIT approach. By end of 2019, 90% of estimated PLHIV will be identified and know their status. By end of 2019, 90% of identified cases will be put on ARV treatment. By end of 2019, 80% of people on ARV will be virally suppressed The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division Olivier, CAVEY Fund Portfolio Manager +41 58 791 1700 olivier.cavey@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Iran (Islamic Republic) HIV Multicomponent RSSH HIV -> Comprehensive prevention programs for MSM -> Other intervention(s) for MSM HIV -> Comprehensive prevention programs for people who inject drugs (PWID) and their partners -> HIV testing services for PWID HIV -> Comprehensive prevention programs for people who inject drugs (PWID) and their partners -> OST and other drug dependence treatment for PWID HIV -> Comprehensive prevention programs for people who inject drugs (PWID) and their partners -> Other intervention(s) for IDUs and their partners HIV -> Comprehensive prevention programs for sex workers and their clients -> HIV testing services for sex workers HIV -> Comprehensive prevention programs for sex workers and their clients -> Other intervention(s) for sex workers and their clients HIV -> Comprehensive prevention programs for TGs -> Other intervention(s) for TGs HIV -> Comprehensive programs for people in prisons and other closed settings -> HIV testing services for people in prisons and other closed settings HIV -> Comprehensive programs for people in prisons and other closed settings -> Other intervention(s) for people in prisons and other closed settings HIV -> Comprehensive programs for people in prisons and other closed settings -> Prevention and management of coinfections and co-morbidities for people in prisons and other closed settings HIV -> PMTCT -> Prong 3: Preventing vertical HIV transmission HIV -> Treatment, care and support -> Counseling and psycho-social support HIV -> Treatment, care and support -> Differentiated ART service delivery HIV -> Treatment, care and support -> Treatment monitoring - Drug resistance HIV -> Treatment, care and support -> Treatment monitoring - Viral load Multicomponent -> COVID-19 -> COVID-19 control and containment including health systems strengthening Multicomponent -> COVID-19 -> Risk mitigation for disease programs Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency RSSH -> RSSH: Health management information systems and M&E -> Program and data quality RSSH -> RSSH: Health products management systems -> Supply chain infrastructure and development of tools RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting RSSH -> RSSH: Monitoring and evaluation systems -> Surveys 2932517.95 328472.41 1533186.57 7004827.51 427535.00 Global Fund Commitment to IRN-H-UNDPP02. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 1417955.49 Global Fund Commitment to IRN-H-UNDPP02. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 6217980.44 Global Fund Commitment to IRN-H-UNDPP02. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 3425818.17 Global Fund Commitment to IRN-H-UNDPP02. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 3425818.17 Global Fund disbursement to IRN-H-UNDPP02. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 427535.00 Global Fund disbursement to IRN-H-UNDPP02. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 594031.72 Global Fund disbursement to IRN-H-UNDPP02. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 1510061.18 Global Fund disbursement to IRN-H-UNDPP02. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 1820138.78 Global Fund disbursement to IRN-H-UNDPP02. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 2293748.76 Global Fund disbursement to IRN-H-UNDPP02. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 1417955.49 Global Fund disbursement to IRN-H-UNDPP02. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) <narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative> An overview of a grant over it's lifetime. <narrative xml:lang="en">Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative xml:lang="en">Coverage / Output indicators targets and results for IRN-H-UNDPP02</narrative> <narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative> <narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative> <narrative xml:lang="en">KP-Other 1: Percentage of Prisoners that have received HIV test during the reporting period and know their status</narrative> <narrative xml:lang="en">Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> <narrative xml:lang="en">Percentage of people living with HIV and on ART, who have a suppressed viral load at 12 months (<1000 copies/ml)</narrative> <narrative xml:lang="en">Impact indicators targets and results for IRN-H-UNDPP02</narrative> <narrative xml:lang="en">Number of AIDS-related deaths per 100,000 population</narrative> <narrative xml:lang="en">Percentage of sex workers who are living with HIV</narrative> <narrative xml:lang="en">Outcome indicators targets and results for IRN-H-UNDPP02</narrative> <narrative xml:lang="en">Percentage of (estimated) people living with HIV who have been tested HIV-positive</narrative> <narrative xml:lang="en">Percentage of adults and children with HIV, known to be on treatment 12 months after initiation of antiretroviral therapy</narrative> <narrative xml:lang="en">Percentage of sex workers reporting using a condom with their most recent client</narrative> 47045-IRN-H-UNDP-3 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative xml:lang="en">Enhancement of National HIV Response with Focus on Target Beneficiary Groups in line with fifth National Strategic Plan 2020-2024 - Iran (Islamic Republic) (01-Apr-2021-31-Mar-2024)</narrative> Iran (Islamic Republic), HIV, United Nations Development Programme (UNDP Iran)This program has the following goals: By the end of 2023, maintain the HIV prevalence among PWIDs at less than 5%. By the end of 2023, maintain the HIV prevalence among people who are exposed to sexual transmission of HIV at less than 5%. By the end of 2023, decrease the AIDS mortality by 20%. The objectives of this program are: By the end of 2023, at least 60% of the PWIDs use sterilized and non-shared devices for injection in their last injection. By the end of 2023, the percentage of condom use in the last sex among people who are at the highest risk of sexual transmission increases by 20%. By the end of 2023, at least 92% of people living with HIV and started their treatment a year ago, retain their treatment The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division Olivier, CAVEY Fund Portfolio Manager +41 58 791 1700 olivier.cavey@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Iran (Islamic Republic) HIV Multicomponent RSSH Tuberculosis HIV -> Differentiated HIV Testing Services -> Facility-based testing HIV -> Prevention -> Community empowerment HIV -> Prevention -> Condom and lubricant programing HIV -> Prevention -> Harm reduction interventions for drug use HIV -> Prevention -> Needle and syringe programs HIV -> Prevention -> Sexual and reproductive health services, including STIs HIV -> Treatment, care and support -> Differentiated ART service delivery and HIV care HIV -> Treatment, care and support -> Treatment monitoring - Drug resistance HIV -> Treatment, care and support -> Treatment monitoring - Viral load Multicomponent -> COVID-19 -> Case management, clinical operations and therapeutics Multicomponent -> COVID-19 -> COVID diagnostics and testing Multicomponent -> COVID-19 -> COVID-19 CSS: Community-based organizations institutional capacity building Multicomponent -> COVID-19 -> COVID-19 CSS: Community-led monitoring Multicomponent -> COVID-19 -> Health products and waste management systems Multicomponent -> COVID-19 -> Infection prevention and control, and protection of the health workforce Multicomponent -> COVID-19 -> Laboratory systems Multicomponent -> COVID-19 -> Mitigation for HIV programs Multicomponent -> COVID-19 -> Risk communication Multicomponent -> COVID-19 -> RSSH/PP: Community health workers: In-service training Multicomponent -> COVID-19 -> Surveillance systems Multicomponent -> COVID-19 -> Surveillance: Epidemiological investigation and contact tracing Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency RSSH -> RSSH: Health management information systems and M&E -> Program and data quality RSSH -> RSSH: Human resources for health, including community health workers -> Community health workers: In-service training Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis 5907614.85 3793322.53 5267505.30 2089725.11 6495494.61 Global Fund Commitment to IRN-H-UNDPP03. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 3912351.04 Global Fund Commitment to IRN-H-UNDPP03. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 701399.83 Global Fund Commitment to IRN-H-UNDPP03. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 5640656.00 Global Fund Commitment to IRN-H-UNDPP03. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) -274741.00 Global Fund Commitment to IRN-H-UNDPP03. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 133791.00 Global Fund Commitment to IRN-H-UNDPP03. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 5640656.00 Global Fund disbursement to IRN-H-UNDPP03. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 3673468.00 Global Fund disbursement to IRN-H-UNDPP03. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 133791.00 Global Fund disbursement to IRN-H-UNDPP03. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) -274741.00 Global Fund disbursement to IRN-H-UNDPP03. United Nations Development Programme (UNDP Iran) The Global Fund to Fight AIDS, Tuberculosis and Malaria 238883.04 Global Fund disbursement to IRN-H-UNDPP03. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 6495494.61 Global Fund disbursement to IRN-H-UNDPP03. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 701399.83 Global Fund disbursement to IRN-H-UNDPP03. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) <narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative> An overview of a grant over it's lifetime. <narrative xml:lang="en">Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative xml:lang="en">Coverage / Output indicators targets and results for IRN-H-UNDPP03</narrative> <narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative> <narrative xml:lang="en">Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Number of people in prisons and other closed settings reached with HIV prevention programs - defined package of services</narrative> <narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative> <narrative xml:lang="en">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative> <narrative xml:lang="en">Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> <narrative xml:lang="en">Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative> <narrative xml:lang="en">Outcome indicators targets and results for IRN-H-UNDPP03</narrative> <narrative xml:lang="en">Percentage of people living with HIV who know their HIV status at the end of the reporting period</narrative> <narrative xml:lang="en">Percentage of people living with HIV and on ART who are virologically suppressed</narrative> 47045-IRN-H-UNDP-4 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative xml:lang="en">Enhancement of National HIV Response with Focus on Target Beneficiary Groups in line with fifth National Strategic Plan 2020-2026 - Iran (Islamic Republic) (01-Apr-2024-31-Mar-2027)</narrative> Iran (Islamic Republic), HIV, United Nations Development Programme (UNDP Iran)This program has the following goals: By the end of March 2027, maintain HIV prevalence among PWIDs at less than 5%. By the end of March 2027, maintain the HIV prevalence among people who are exposed to sexual transmission of HIV at less than 5%. By the end of March 2027, decrease the AIDS mortality by 20%. The objectives of this program are: By the end of 2027, at least 60% of the PWIDs use sterilized and non-shared devices for injection in their last injection. By the end of 2027, the percentage of condom use in the last sex among people who are at the highest risk of sexual transmission increases by 20%. By the end of 2027, at least 92% of people living with HIV and started their treatment a year ago, retain their treatment The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division Olivier, CAVEY Fund Portfolio Manager +41 58 791 1700 olivier.cavey@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Iran (Islamic Republic) HIV Multicomponent RSSH Tuberculosis HIV -> Differentiated HIV Testing Services -> Community-based testing for KP programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for key population (KP) programs HIV -> Differentiated HIV Testing Services -> Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs HIV -> Differentiated HIV Testing Services -> Self-testing for KP programs HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Early infant diagnosis and follow-up HIV testing for exposed infants HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Integrated testing of pregnant women for HIV, syphilis and hepatitis B HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Condom and lubricant programing for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Pre-exposure prophylaxis (PrEP) programing for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM HIV -> Prevention package for other vulnerable populations (OVP) -> Condom and lubricant programing for OVP HIV -> Prevention package for other vulnerable populations (OVP) -> Pre-exposure prophylaxis (PrEP) programing for OVP HIV -> Prevention package for people in prisons and other closed settings -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for prisoners HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Condom and lubricant programing for PUD HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Needle and syringe programs for PWID HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for PUD HIV -> Prevention package for sex workers, their clients and other sexual partners -> Condom and lubricant programing for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Pre-exposure prophylaxis (PrEP) programing for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers HIV -> Prevention package for transgender people and their sexual partners -> Condom and lubricant programing for transgender people HIV -> Treatment, care and support -> Diagnosis and management of advanced disease (adults and children) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above) HIV -> Treatment, care and support -> Integrated management of common co-infections and co-morbidities (adults and children) HIV -> Treatment, care and support -> Treatment monitoring - Viral load and antiretroviral (ARV) toxicity Multicomponent -> Program management -> Grant management RSSH -> RSSH: Monitoring and evaluation systems -> Analyses, evaluations, reviews and data use RSSH -> RSSH: Monitoring and evaluation systems -> Data quality RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Community health workers: contracting, remuneration and retention RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: In-service training (excluding community health workers) RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Remuneration and deployment of existing/new staff (excluding community health workers) Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis 4244477.99 5871104.29 2223592.85 1198065.24 Global Fund Commitment to IRN-H-UNDPP04. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 2476291.00 Global Fund Commitment to IRN-H-UNDPP04. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 6255463.78 Global Fund Commitment to IRN-H-UNDPP04. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 2914862.00 Global Fund Commitment to IRN-H-UNDPP04. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) -2523717.22 Global Fund Commitment to IRN-H-UNDPP04. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 2914862.00 Global Fund disbursement to IRN-H-UNDPP04. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 1198065.24 Global Fund disbursement to IRN-H-UNDPP04. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) 3731746.56 Global Fund disbursement to IRN-H-UNDPP04. Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme (UNDP Iran) <narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative> An overview of a grant over it's lifetime. <narrative xml:lang="en">Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants.